Their forecasts range from C$3.50 to C$4.25. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. CloudMD Software & Services Inc. analyst estimates, including DOCRF earnings per share estimates and analyst recommendations. By continuing to use our service, you agree to our use of cookies. The current price… Their forecasts range from $3.25 to $3.50. Click here to find out more about our partners. 2 analysts have issued 1-year price targets for CloudMD Software & Services' stock. Their forecasts range from $3.25 to $3.50. CloudMD Software & Services has received 11 “outperform” votes. On average, they anticipate CloudMD Software & Services' share price to reach $3.38 in the next year. CloudMD is part of CloudMD Software & Services Inc.. Investors may trade in the Pre-Market (4:00-9:30 a.m. View real-time stock prices and stock quotes for a full financial overview. CloudMD Software & Services does not currently pay a dividend. CloudMD Software & Services' management team includes the following people: Start Your Risk-Free Trial Subscription Here, Blowout Results May Not Sustain Target’s Rally, Under Armour Shares Gap Lower As Judge OK's Shareholder Lawsuit, The Container Store Has What Every Growth Stocks Needs, Don’t Rush To Buy Walmart, Extra Low Prices Are On The Way, Legal Issues Behind It, IBIO Stock May Be a Long Play For Risk-Tolerant Investors, Steel Producers Extend Their One-Year Gains On Strong Demand, Lumentum Stock Providing Opportunistic Pullbacks, 7 Cyclical Stocks That Can Help You Play Defense, 7 Stocks That Could Benefit From a Capital Gains Tax Hike, 7 Forever Stocks That Are Never Bad to Buy, 7 Stocks That Still Have Upside For Investors to Buy, 7 Precious Metals Stocks That Will Keep Your Portfolio On Trend, 7 Bellwether Stocks Signaling a Return to Normal, 7 Electric Vehicle (EV) Stocks That Are Ready to Rebound, 7 Sports Betting Stocks That Will Shine Beyond March Madness, 7 Stocks That Cathie Wood is Buying And You Should Too, 7 Internet of Things Stocks That Are a Perfect Fit to Our Connected Future, 7 Undervalued Stocks That Deserve More Attention, CloudMD Closes Acquisition of Rxi, Providing an Established Specialty Drug Management and Patient Support Program to the Employer Market, CloudMD Software & Services (OTCMKTS:DOCRF) Trading Up 3.3%, Cloudmd Software & Services Inc. (DOC-X) Quote - Press Release - The Globe and Mail, CloudMD Reports Record Fourth Quarter 2020 Revenue; On Track for Significant Growth in 2021, CloudMD to Participate in Upcoming Laurentian Bank and Bloom Burton & Co. Investor Conferences, CloudMD Announces Rapid Growth of Enterprise Health Solutions Division, CloudMD Announces Closing of $8.2 Million Over-Allotment Option, CloudMD Announces Closing of $8.2 Million Over-Allotment Option, CloudMD Announces Closing of $55 Million Bought Deal Financing, Medavie Blue Cross partners with Medical Confidence to create new way to support Canadians on disability waiting for a specialist, view top-rated stocks among Wall Street analysts, Receive Analysts' Upgrades and Downgrades Daily. MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. You can opt out at any time. The average price target is $3.09 with a high forecast of $3.30 and a low forecast of $2.89.The average price target represents a 83.93% increase from the last price of $1.68. 326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257 Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. What is TXMD's Earnings Per Share (EPS) forecast for 2021-2023? Sign-up to receive the latest news and ratings for CloudMD Software & Services and its competitors with MarketBeat's FREE daily newsletter. CloudMD Software & Services has received 100.00% “outperform” votes from our community. (Add your “underperform” vote.). Real-time Price Updates for Cloudmd Software & Services Inc. (DOC-X). CloudMD (DOC-CSE) is my favourite way to play Tele-Health. The successful prediction of Cloudmd Software stock future price could yield a significant profit. It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. CloudMD Software & Services does not have a long track record of dividend growth. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. The deal will cost CloudMD C$60 million along with a potential one-time C$40 million earnout. Some companies that are related to CloudMD Software & Services include 1st Group (1ST), Alcidion Group (ALC), Alternate Health (AHGIF), Binovi Technologies (BNVIF), Cann American (CNNA), CannaOne Technologies (CNONF), CloudMD Software & Services (DOC), Cogstate (CGS), Corum Group (COO), EGF Theramed Health (EVAHF), Emyria (EMD), eWellness Healthcare (EWLL), Forian (FORA), Global Health (GLH) and ICS Global (ICS). Find real-time DOCRF - CloudMD Software & Services Inc stock quotes, company profile, news and forecasts from CNN Business. Cloudmd Software Services stock price prediction is an act of determining the future value of Cloudmd Software shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. Learn about financial terms, types of investments, trading strategies and more. CloudMD Closes Acquisition of Rxi, Providing an Established Specialty Drug Management and Patient Support Program to the Employer Market. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. ), CloudMD Software & Services has received 0 “underperform” votes. 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for CloudMD Software & Services in the last year. By comparison, WELL stock is trading at a P/S ratio of 30.4. This is slightly up from the average last month, which was C$3.45. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. CloudMD Software & Services has only been the subject of 1 research reports in the past 90 days. This suggests a possible upside of 112.3% from the stock's current price. On 2021-05-14, CloudMD (DOC-X) stock closed at a price of $1.95. Receive a free world-class investing education from MarketBeat. ... 5:58a Seagate Technology stock price … Export data to Excel for your own analysis. On average, they expect CloudMD Software & Services' stock price to reach C$3.88 in the next twelve months. CloudMD stock has soared more than 200% since its debut at TSXV in June of this year. See what's happening in the market right now with MarketBeat's real-time news feed. 2 equities research analysts have issued twelve-month target prices for CloudMD Software & Services' stock. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. According to analysts' consensus price target of $3.38, CloudMD Software & Services has a forecasted upside of 120.2% from its current price of $1.53. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. The average TherapeuticsMD stock price prediction forecasts a potential downside of N/A from the current TXMD share price of $1.06. Free real-time prices and the UK's most active stock market forums. (NASDAQ: TXMD) TherapeuticsMD's current Earnings Per Share (EPS) is -$0.57. The average price target is $3.38, with a high forecast of $3.50 and a low forecast of $3.25. The C$60 million comes in one C$30 million cash payment and one C$30 million payment in common … On average, they expect CloudMD Software & Services' stock price to reach $3.38 in the next year. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Fundamental company data provided by Zacks Investment Research. MarketBeat thinks these five companies may be even better buys.View MarketBeat's top stock picks here. One share of DOCRF stock can currently be purchased for approximately $1.53. There are currently 2 buy ratings for the stock. This price target is based on 2 analysts offering 12 month price targets for CloudMD Software & Services in the last 3 months. Get short term trading ideas from the MarketBeat Idea Engine. Wall Street analysts have given CloudMD Software & Services a "Buy" rating, but there may be better buying opportunities in the stock market. (Add your “outperform” vote. CloudMD Software & Services has received a consensus rating of Buy. 2 Wall Street analysts have issued 1-year price targets for CloudMD Software & Services' shares. CloudMD Software & Services Inc Forecast, Short-Term " DOCRF" Stock Price Prognosis for Next Days Walletinvestor.com DOCRF Forecast, Long-Term Price Predictions for Next Months and Year: 2021, 2022 View which stocks are hot on social media with MarketBeat's trending stocks report. Relative to the current share price of CA$2.1, the company appears quite undervalued at a 37% discount to where the stock price trades currently. You can select 'Manage settings' for more information and to manage your choices. MarketBeat's community ratings are surveys of what our community members think about CloudMD Software & Services and other stocks. Information about your device and internet connection, including your IP address, Browsing and search activity while using Verizon Media websites and apps. CloudMD Software & Services Inc (DOCRF) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. Want to see which stocks are moving? The average price target represents a 103.31% upside from the last price of $1.66. CloudMD has access to Rxi’s network of 500 independent pharmacies to provide better, more localized, access to care. The average price target is C$3.88, with a high forecast of C$4.25 and a low forecast of C$3.50. Vote “Outperform” if you believe DOCRF will outperform the S&P 500 over the long term. (82.32% Upside) Based on 2 analysts offering 12 month price targets for CloudMD Software & Services in the last 3 months. Please log in to your account or sign up in order to add this asset to your watchlist. Identify stocks that meet your criteria using seven unique stock screeners. View our full suite of financial calendars and market data tables, all for free. The average price target is C$3.74 with a high forecast of C$3.99 and a low forecast of C$3.49. Looking for new stock ideas? Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. MarketBeat just released five new stock ideas, but CloudMD Software & Services wasn't one of them. To see all exchange delays and terms of use please see disclaimer. View all of DOCRF's competitors. In the past three months, CloudMD Software & Services insiders have not sold or bought any company stock. The assumptions in any calculation have a big impact on the valuation, so it is better to view this as a rough estimate, not precise down to the last cent. Compare Top Brokerages Here. CloudMD: Canaccord Raises Price Target To $3.75. One analyst has a strong buy rating, while the other three have buy ratings on the company. Learn more about MarketBeat. CloudMD Software & Services Inc stock and Healthcare market discussion, news, and analysis from Canada's largest community of active investors Stockhouse.com use cookies on this site.
Four Paws Austria,
Best Books On Bitcoin,
Tips To Make Your Job Easier,
Curse Of The Mayans,
What Shaped The Wall Arch,
Pull Morgan Nouvelle Collection,
Gramatika Ng Wikang Filipino Pdf,
Tinman Elite Necklace,
Afcb Ticket Office Number,